Package 0536-1213-88

{"route": ["ORAL"], "spl_id": "74767680-e4e7-4ba6-8d45-a01cd0471317", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0305361213886"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1099074"], "spl_set_id": ["2c9515f8-3120-4dbb-a7fc-d89fc5727148"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Rugby Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "14 BLISTER PACK in 1 CARTON (0536-1213-88)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "0536-1213-88", "marketing_end_date": "20260928", "marketing_start_date": "20181105"}], "brand_name": "Maximum Strength Guaifenesin DM", "product_id": "0536-1213_74767680-e4e7-4ba6-8d45-a01cd0471317", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "0536-1213", "generic_name": "Guaifenesin, Dextromethorphan HBr", "labeler_name": "Rugby Laboratories", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Maximum Strength Guaifenesin DM", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "60 mg/1"}, {"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA209692", "marketing_category": "ANDA", "marketing_end_date": "20260928", "marketing_start_date": "20181105"}